Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features

Fig. 3

The images illustrate (A) the interaction between the wild-type protein and L-carnitine, (B) the interaction between the mutant protein and L-carnitine, (C) the 3D structure of normal organic carnitine transporter type 2 (OCTN2) (green) in interaction with L-carnitine, and (D) the 3D structure of the mutant OCTN2 (blue) in interaction with L-carnitine

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us